Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32102| Title: | Variability of the response to immunotherapy among sub-groups of patients with multiple sclerosis. | Austin Authors: | Diouf, Ibrahima;Malpas, Charles B;Sharmin, Sifat;Roos, Izanne;Horakova, Dana;Havrdova, Eva Kubala;Patti, Francesco;Shaygannejad, Vahid;Ozakbas, Serkan;Izquierdo, Guillermo;Eichau, Sara;Onofrj, Marco;Lugaresi, Alessandra;Alroughani, Raed;Prat, Alexandre;Girard, Marc;Duquette, Pierre;Terzi, Murat;Boz, Cavit;Grand'Maison, Francois;Hamdy, Sherif;Sola, Patrizia;Ferraro, Diana;Grammond, Pierre;Turkoglu, Recai;Buzzard, Katherine;Skibina, Olga;Yamout, Bassem;Altintas, Ayse;Gerlach, Oliver;van Pesch, Vincent;Blanco, Yolanda;Maimone, Davide;Lechner-Scott, Jeannette;Bergamaschi, Roberto;Karabudak, Rana;Iuliano, Gerardo;McGuigan, Chris;Cartechini, Elisabetta;Barnett, Michael;Hughes, Stella;Sa, Maria José;Solaro, Claudio;Kappos, Ludwig;Ramo-Tello, Cristina;Cristiano, Edgardo;Hodgkinson, Suzanne;Spitaleri, Daniele;Soysal, Aysun;Petersen, Thor;Slee, Mark;Butler, Ernest;Granella, Franco;de Gans, Koen;McCombe, Pamela;Ampapa, Radek;Van Wijmeersch, Bart;van der Walt, Anneke;Butzkueven, Helmut;Prevost, Julie;Sinnige, L G F;Sanchez-Menoyo, Jose Luis;Vucic, Steve;Laureys, Guy;Van Hijfte, Liesbeth;Khurana, Dheeraj;Macdonell, Richard A L ;Gouider, Riadh;Castillo-Triviño, Tamara;Gray, Orla;Aguera-Morales, Eduardo;Al-Asmi, Abdullah;Shaw, Cameron;Deri, Norma;Al-Harbi, Talal;Fragoso, Yara;Csepany, Tunde;Perez Sempere, Angel;Trevino-Frenk, Irene;Schepel, Jan;Moore, Fraser;Kalincik, Tomas | Affiliation: | CORe, Department of Medicine, University of Melbourne, Melbourne, Australia. CORe, Department of Medicine, University of Melbourne, Melbourne, Australia. Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic. Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania, Italy. Isfahan University of Medical Sciences, Isfahan, Iran. Dokuz Eylul University, Konak/Izmir, Turkey. Hospital Universitario Virgen Macarena, Sevilla, Spain. Department of Neuroscience, Imaging, and Clinical Sciences, University G. díAnnunzio, Chieti, Italy. IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy. Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait. CHUM, MS Center and Universite de Montreal, Montreal, Canada. School of Medicine, Ondokuz Mayis University. KTU Medical Faculty Farabi Hospital, Trabzon, Turkey. Neuro Rive-Sud, Quebec, Canada. Neurology, Kasr Al Ainy MS research Unit (KAMSU), Cairo, Cairo. Department of Neuroscience, Azienda Ospedaliera Universitaria, Modena, Italy. CISSS ChaudiËre-Appalache, Levis, Canada. Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey. Central Clinical School, Monash University, Melbourne, Australia. Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon. Department of Neurology, School of Medicine, Koc University. Zuyderland Medical Centre, Sittard-Geleen, Netherlands. Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium. Center of Neuroimmunology, Service of Neurology, Hospital Clinic de Barcelona, Barcelona, Spain. Garibaldi Hospital, Catania, Italy. School of Medicine and Public Health, University Newcastle, Newcastle, Australia. IRCCS Mondino Foundation, Pavia, Italy. Hacettepe University, Ankara, Turkey. Ospedali Riuniti di Salerno, Salerno, Italy. St Vincent's University Hospital, Dublin, Ireland. UOC Neurologia, Azienda Sanitaria Unica Regionale Marche - AV3, Macerata, Italy. Brain and Mind Centre, Sydney, Australia. Royal Victoria Hospital, Belfast, United Kingdom. Department of Neurology, Centro Hospitalar Universitário de São João, Porto, Portugal. Department of Neurology, ASL3 Genovese, Genova, Italy. Neurologic Clinic and Policlinic, Departments of Medicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland. Hospital Germans Trias i Pujol, Badalona, Spain. Hospital Italiano, Buenos Aires, Argentina. Liverpool Hospital, Sydney, Australia. Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy. Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey. Aarhus University Hospital, Arhus C, Denmark. Flinders University, Adelaide, Australia. Monash Medical Centre, Melbourne, Australia. Department of Medicine and Surgery, University of Parma, Parma, Italy. Groene Hart Ziekenhuis, Gouda, Netherlands. University of Queensland, Brisbane, Australia. Nemocnice Jihlava, Jihlava, Czech Republic. Rehabilitation and MS-Centre Overpelt and Hasselt University, Hasselt, Belgium. Central Clinical School, Monash University, Melbourne, Australia. Austin Health CSSS Saint-Jerome, Saint-Jerome, Canada. Medical Center Leeuwarden, Leeuwarden, Netherlands. Hospital de Galdakao-Usansolo, Galdakao, Spain. Westmead Hospital, Sydney, Australia. Universitary Hospital Ghent, Ghent, Belgium. PGIMER, Chandigarh, India. Department of Neurology, Razi Hospital, Manouba, Tunisia. Instituto de Investigacion Sanitaria Biodonostia, Hospital Universitario Donostia, San Sebastian, Spain. South East Trust, Belfast, United Kingdom. University Hospital Reina Sofia, Cordoba, Spain. Department of Medicine, Sultan Qaboos University Hospital, Al-Khodh, Oman. University Hospital Geelong, Australia. Hospital Fernandez, Capital Federal, Argentina. Neurology Department, King Fahad Specialist Hospital-, Dammam, Saudi Arabia. Universidade Metropolitana de Santos, Santos, Brazil. Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Hospital General Universitario de Alicante, Alicante, Spain. Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico. Waikato Hospital, Hamilton, New Zealand; 75Jewish General Hospital, Montreal, Canada. CORe, Department of Medicine, University of Melbourne, Melbourne, Australia. |
Issue Date: | 24-Jan-2023 | Date: | 2023 | Publication information: | European Journal of Neurology 2023; 30:1014–1024 | Abstract: | This study assessed the effect of patient characteristics on the response to disease modifying therapy (DMT) in in multiple sclerosis (MS). | URI: | https://ahro.austin.org.au/austinjspui/handle/1/32102 | DOI: | 10.1111/ene.15706 | ORCID: | 0000-0003-0371-3666 0000-0002-6923-0846 0000-0002-3586-9115 0000-0003-4818-3806 0000-0002-2540-6651 0000-0003-2885-9004 0000-0002-1834-0498 0000-0001-6167-3987 0000-0003-2634-8294 0000-0002-0956-4633 0000-0001-8726-089X 0000-0003-3778-1376 |
Journal: | European Journal of Neurology | Start page: | 1014 | End page: | 1024 | PubMed URL: | 36692895 | ISSN: | 1468-1331 | Type: | Journal Article | Subjects: | EDSS immunotherapy marginal structural model multiple sclerosis relapse Multiple Sclerosis/therapy |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.